[1] |
SRIRANGAM NADHAMUNI V, KORBONITS M. Novel insights into pituitary tumorigenesis: Genetic and epigenetic mechanisms[J]. Endocr Rev, 2020, 41(6): 821. doi: 10.1210/endrev/bnaa006 |
[2] |
CHENG J, NIE D, LI B, et al. CircNFIX promotes progression of pituitary adenoma via CCNB1 by sponging miR-34a-5p[J]. Mol Cell Endocrinol, 2021, 525: 111140. doi: 10.1016/j.mce.2020.111140 |
[3] |
HONG CS, KUNDISHORA AJ, ELSAMADICY AA, et al. Somatic NF1 mutations in pituitary adenomas: report of two cases[J]. Cancer Genet, 2021: 26. |
[4] |
LUONGO F, COLONNA F, CALAPÀ F, et al. PTEN tumor-suppressor: The dam of stemness in cancer[J]. Cancers(Basel), 2019, 11(8): 1076. |
[5] |
HANNA C, DUNNE VL, WALKER SM, et al. ATM kinase inhibition preferentially sensitises PTEN-deficient prostate tumour cells to ionising radiation[J]. Cancers(Basel), 2020, 13(1): 79. |
[6] |
XU W, ZHANG M, LI Y, et al. YAP manipulates proliferation via PTEN/AKT/mTOR-mediated autophagy in lung adenocarcinomas[J]. Cancer Cell Int, 2021, 21(1): 30. doi: 10.1186/s12935-020-01688-9 |
[7] |
ZHANG J, LI X, ZHANG Y. Correlation of NEDD4-1 and PTEN expression with the invasive capacity of pituitary adenomas[J]. Mol Clin Oncol, 2017, 6(1): 96. doi: 10.3892/mco.2016.1092 |
[8] |
ZHENG Z, ZHANG Y, ZHANG Z, et al. Effect of miR-106b on Invasiveness of Pituitary Adenoma via PTEN-PI3K/AKT[J]. Med Sci Monit, 2017, 23: 1277. doi: 10.12659/MSM.900092 |
[9] |
LIU L, HE J, WEI X, et al. MicroRNA-20a-mediated loss of autophagy contributes to breast tumorigenesis by promoting genomic damage and instability[J]. Oncogene, 2017, 36(42): 5874. doi: 10.1038/onc.2017.193 |
[10] |
BRUE T, CASTINETTI F. The risks of overlooking the diagnosis of secreting pituitary adenomas[J]. Orphanet J Rare Dis, 2016, 11(1): 135. doi: 10.1186/s13023-016-0516-x |
[11] |
WEI D, YU Z, CHENG Y, et al. Dysregulated miR-137 and its target EGFR contribute to the progression of pituitary adenomas[J]. Mol Cell Endocrinol, 2021, 520: 111083. doi: 10.1016/j.mce.2020.111083 |
[12] |
CHENG D, ZHAO S, TANG H, et al. MicroRNA-20a-5p promotes colorectal cancer invasion and metastasis by downregulating Smad[J]. Oncotarget, 2016, 7(29): 45199. doi: 10.18632/oncotarget.9900 |
[13] |
YANG R, FU Y, ZENG Y, et al. Serum miR-20a is a promising biomarker for gastric cancer[J]. Biomed Rep, 2017, 6(4): 429. doi: 10.3892/br.2017.862 |
[14] |
LIU L, HE J, WEI X, et al. MicroRNA-20a-mediated loss of autophagy contributes to breast tumorigenesis by promoting genomic damage and instability[J]. Oncogene, 2017, 36(42): 5874. doi: 10.1038/onc.2017.193 |
[15] |
WEI Z, ZHOU C, LIU M, et al. MicroRNA involvement in a metastatic non-functioning pituitary carcinoma[J]. Pituitary, 2015, 18(5): 710. doi: 10.1007/s11102-015-0648-3 |
[16] |
LEE YR, CHEN M, PANDOLFI PP. The functions and regulation of the PTEN tumour suppressor: new modes and prospects[J]. Nat Rev Mol Cell Biol, 2018, 19(9): 547. doi: 10.1038/s41580-018-0015-0 |